Who Doxy-PEP Is Actually Recommended For

Who is doxy-PEP recommended for?

The CDC's 2024 guideline recommends that clinicians counsel and offer doxy-PEP to two groups: men who have sex with men, and transgender women, who have been diagnosed with at least one bacterial STI — syphilis, chlamydia, or gonorrhea — in the previous 12 months 1Ref 1Bachmann LH, Barbee LA, Chan P, et al. (Centers for Disease Control and Prevention) (2024).CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.That the 2024 CDC guideline recommends counseling and offering doxy-PEP (a dose of doxycycline taken within 72 hours after sex) to men who have sex with men and transgender women who had syphilis, chlamydia, or gonorrhea in the prior 12 months, with STI testing every 3-6 months; and that the recommendation does not extend to cisgender women.. That prior infection is the entry point: it identifies people whose risk of getting another bacterial STI is high enough that a preventive dose after sex is likely to help 2Ref 2Centers for Disease Control and Prevention (2024).Doxy PEP for Bacterial STI Prevention.The provider-facing summary of the doxy-PEP recommendation and its target population, supporting the same eligibility framing that a recent bacterial STI identifies higher-risk people the intervention is aimed at..

Doxy-PEP is post-exposure prophylaxis with the antibiotic doxycycline — a single dose taken after sex to lower the risk of certain bacterial STIs.

Doxy-PEP means taking a single dose of the antibiotic doxycycline within 72 hours after sex. It is prevention against bacterial STIs, aimed at the people the evidence studied most directly. If you fall outside that description, it does not mean the door is closed forever — but it does mean the current recommendation was not written with your situation as its primary case 1Ref 1Bachmann LH, Barbee LA, Chan P, et al. (Centers for Disease Control and Prevention) (2024).CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.That the 2024 CDC guideline recommends counseling and offering doxy-PEP (a dose of doxycycline taken within 72 hours after sex) to men who have sex with men and transgender women who had syphilis, chlamydia, or gonorrhea in the prior 12 months, with STI testing every 3-6 months; and that the recommendation does not extend to cisgender women..

What counts as a bacterial STI in the past year?

The three infections that qualify are the bacterial STIs doxy-PEP is shown to reduce: syphilis, chlamydia, and gonorrhea 1Ref 1Bachmann LH, Barbee LA, Chan P, et al. (Centers for Disease Control and Prevention) (2024).CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.That the 2024 CDC guideline recommends counseling and offering doxy-PEP (a dose of doxycycline taken within 72 hours after sex) to men who have sex with men and transgender women who had syphilis, chlamydia, or gonorrhea in the prior 12 months, with STI testing every 3-6 months; and that the recommendation does not extend to cisgender women.. A documented diagnosis of any one of them in the prior 12 months is what the guideline uses to define higher risk. It is a concrete, checkable threshold rather than a judgment call about someone's sex life.

Doxycycline is an antibiotic, so doxy-pep does nothing against viral infections like HIV, herpes, or HPV, and it is not aimed at trichomoniasis. Its whole job is the three bacterial infections named above — and even there, its measured benefit is strongest against syphilis and chlamydia 1Ref 1Bachmann LH, Barbee LA, Chan P, et al. (Centers for Disease Control and Prevention) (2024).CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.That the 2024 CDC guideline recommends counseling and offering doxy-PEP (a dose of doxycycline taken within 72 hours after sex) to men who have sex with men and transgender women who had syphilis, chlamydia, or gonorrhea in the prior 12 months, with STI testing every 3-6 months; and that the recommendation does not extend to cisgender women..

Why doxy-PEP is an offer, not an automatic prescription

The guideline's wording is deliberate: clinicians are advised to counsel and offer doxy-PEP and to decide together with the patient, not to prescribe it reflexively 1Ref 1Bachmann LH, Barbee LA, Chan P, et al. (Centers for Disease Control and Prevention) (2024).CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.That the 2024 CDC guideline recommends counseling and offering doxy-PEP (a dose of doxycycline taken within 72 hours after sex) to men who have sex with men and transgender women who had syphilis, chlamydia, or gonorrhea in the prior 12 months, with STI testing every 3-6 months; and that the recommendation does not extend to cisgender women.. That is shared decision-making, the approach a good clinician uses when a choice depends on someone's values and circumstances as much as on the evidence. AHRQ describes it as a five-step process: seek the person's participation, help them compare options, assess what matters to them, reach a decision together, and evaluate it 3Ref 3Agency for Healthcare Research and Quality (2020).The SHARE Approach.That shared decision making is a five-step process — seek the patient's participation, help them compare options, assess values and preferences, reach a decision together, and evaluate it — which frames doxy-PEP as an offer decided with a clinician..

For doxy-PEP, that conversation covers how often you are having the kinds of encounters where it helps, how you feel about taking an antibiotic after sex, and questions about resistance. None of that is a barrier — it is the point. The recommendation treats you as the person best placed to weigh a preventive antibiotic against its trade-offs.

What about cisgender women, and everyone outside the group?

The current recommendation does not include cisgender women. The clearest trial in cisgender women did not show the same benefit seen in men who have sex with men and transgender women, so the CDC did not extend the recommendation to them in 2024 1Ref 1Bachmann LH, Barbee LA, Chan P, et al. (Centers for Disease Control and Prevention) (2024).CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.That the 2024 CDC guideline recommends counseling and offering doxy-PEP (a dose of doxycycline taken within 72 hours after sex) to men who have sex with men and transgender women who had syphilis, chlamydia, or gonorrhea in the prior 12 months, with STI testing every 3-6 months; and that the recommendation does not extend to cisgender women.. That is an evidence gap, not a verdict that it could never help — and the question of whether doxy-pep works for women is active enough to have its own page, which covers what the trials found and why.

People outside the named group — including men who have sex with women, and anyone without a bacterial STI in the past year — are also outside the current recommendation. A clinician can still discuss individual circumstances, but the guideline's clear recommendation is written for the group where the evidence is strongest 1Ref 1Bachmann LH, Barbee LA, Chan P, et al. (Centers for Disease Control and Prevention) (2024).CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.That the 2024 CDC guideline recommends counseling and offering doxy-PEP (a dose of doxycycline taken within 72 hours after sex) to men who have sex with men and transgender women who had syphilis, chlamydia, or gonorrhea in the prior 12 months, with STI testing every 3-6 months; and that the recommendation does not extend to cisgender women..

What saying yes to doxy-PEP commits you to

Two things come with doxy-PEP. The first is the routine itself: a single dose of doxycycline taken within 72 hours after sex — sooner is better — rather than a daily pill 1Ref 1Bachmann LH, Barbee LA, Chan P, et al. (Centers for Disease Control and Prevention) (2024).CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.That the 2024 CDC guideline recommends counseling and offering doxy-PEP (a dose of doxycycline taken within 72 hours after sex) to men who have sex with men and transgender women who had syphilis, chlamydia, or gonorrhea in the prior 12 months, with STI testing every 3-6 months; and that the recommendation does not extend to cisgender women.. The second is ongoing STI testing. The guideline pairs doxy-PEP with testing for bacterial STIs every 3 to 6 months, so that infections are still caught and treated and any shift in resistance can be watched 1Ref 1Bachmann LH, Barbee LA, Chan P, et al. (Centers for Disease Control and Prevention) (2024).CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.That the 2024 CDC guideline recommends counseling and offering doxy-PEP (a dose of doxycycline taken within 72 hours after sex) to men who have sex with men and transgender women who had syphilis, chlamydia, or gonorrhea in the prior 12 months, with STI testing every 3-6 months; and that the recommendation does not extend to cisgender women..

That testing cadence fits the broader advice that sexually active men who have sex with men be screened for syphilis, chlamydia, and gonorrhea at regular intervals anyway 4Ref 4Centers for Disease Control and Prevention (2024).Getting Tested for STIs.That sexually active men who have sex with men are advised to be screened for syphilis, chlamydia, and gonorrhea at regular intervals, aligning with the testing cadence paired with doxy-PEP.. In practice, doxy-PEP is less a standalone pill than a package: the after-sex dose, regular testing, and periodic check-ins with a clinician who can adjust the plan.

Doxy-PEP is not HIV PEP or PrEP

It is easy to mix these up because the names rhyme, but they do different jobs. Doxy-PEP uses an antibiotic to prevent bacterial STIs. HIV PEP uses HIV medication, started within 72 hours of a possible HIV exposure and taken for 28 days, to prevent HIV after the fact 5Ref 5Centers for Disease Control and Prevention (2024).Clinical Guidance for PEP.That HIV PEP is HIV medication started within 72 hours of a possible HIV exposure and taken as a 28-day course, distinguishing it from doxy-PEP, which is an antibiotic for bacterial STIs and does not prevent HIV.. PrEP is HIV medication taken before exposure to prevent HIV. Doxy-PEP does not prevent HIV, and it does not replace either of them 1Ref 1Bachmann LH, Barbee LA, Chan P, et al. (Centers for Disease Control and Prevention) (2024).CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024.That the 2024 CDC guideline recommends counseling and offering doxy-PEP (a dose of doxycycline taken within 72 hours after sex) to men who have sex with men and transgender women who had syphilis, chlamydia, or gonorrhea in the prior 12 months, with STI testing every 3-6 months; and that the recommendation does not extend to cisgender women..

For someone who qualifies, these tools can layer: a person might use PrEP for HIV and doxy-PEP for bacterial STIs at the same time, a combining prevention question worth raising with a clinician. The most common worry — whether routine antibiotic use drives doxy-pep resistance — is real and is covered on its own page; it is one of the trade-offs the shared-decision conversation is meant to weigh.